Explore the complete record of transactions filed by Nijhawan Pardeep, Chairman & CEO. Officer active across 1 companies, notably Edesa Biotech, Inc.. Cumulatively, 10 disclosures have been published. Total volume traded: €52k. The latest transaction was filed on 27 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Pardeep Nijhawan is the Chief Executive Officer of Edesa Biotech, Inc. He leads the company with a focus on innovation and the development of biopharmaceutical treatments. Edesa Biotech, Inc. is a biotechnology company that focuses on therapeutic solutions for autoimmune diseases.